BWA
55
-5
AAP
26
-7
NDAQ
57
2
BLK
49
3
RF
61
3
MS
61
2
ED
50
-9
IFF
48
-2
NFLX
58
4
BBY
57
9
AMZN
42
-2
REGN
53
-3
VTR
63
6
PFE
45
-15
DRI
45
5
YUM
58
2
CA
15
6
DVA
47
-4
PCG
54
-4
BSX
42
2
BWA
55
-5
AAP
26
-7
NDAQ
57
2
BLK
49
3
RF
61
3
MS
61
2
ED
50
-9
IFF
48
-2
NFLX
58
4
BBY
57
9
AMZN
42
-2
REGN
53
-3
VTR
63
6
PFE
45
-15
DRI
45
5
YUM
58
2
CA
15
6
DVA
47
-4
PCG
54
-4
BSX
42
2
Financhill
Back

Kimbell Royalty Partners LP Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
29

KRP
Kimbell Royalty Partners LP

Last Price:
$14.76
Seasonality Move:
7.11%
Sell
27

NVO
Novo Nordisk A/S

Last Price:
$36.97
Seasonality Move:
12.55%
Sell
29
Kimbell Royalty Partners LP (KRP) is a Sell

Is Kimbell Royalty Partners LP a Buy, Sell or Hold?

  • The current Kimbell Royalty Partners LP [KRP] share price is $14.76. The Score for KRP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • KRP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRP Stock Price Chart

What is Kimbell Royalty Partners LP's stock price today?

  • The Kimbell Royalty Partners LP share price today is $14.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $36.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 56.87 Buy
Chaikin Money Flow: 917984 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.35 - 14.71) Buy
Bollinger Bands (100): (12.2 - 14.34) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 39.83 Sell
Chaikin Money Flow: 14566902 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.41 - 38.59) Sell
Bollinger Bands (100): (39.84 - 55.48) Sell

KRP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.6 Buy
20-day SMA: 14.54 Buy
50-day SMA: 14.14 Buy
200-day SMA: 13.56 Buy
8-day EMA: 14.56 Buy
20-day EMA: 14.5 Buy
50-day EMA: 14.09 Buy
200-day EMA: 13.68 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.4 Buy
20-day SMA: 37.4 Sell
50-day SMA: 44.19 Sell
200-day SMA: 53.09 Sell
8-day EMA: 36.61 Buy
20-day EMA: 37.8 Sell
50-day EMA: 42.18 Sell
200-day EMA: 54.43 Sell

Kimbell Royalty Partners LP Earnings Growth & KRP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.06 per share, and a decrease next year of $0.13 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.

Kimbell Royalty Partners LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):